Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Is early onset breast cancer with no family history a good criterion for testing BRCA1 and BRCA2 genes? A small population-based study.

Beristain E, Martínez-Bouzas C, Mallabiabarrena G, Tejada MI.

Clin Genet. 2009 Jun;75(6):576-8. doi: 10.1111/j.1399-0004.2008.01137.x. Epub 2009 Mar 23. No abstract available.

PMID:
19320659
2.

Mutational analysis of BRCA1 and BRCA2 genes in Mexican breast cancer patients.

Vidal-Millán S, Taja-Chayeb L, Gutiérrez-Hernández O, Ramírez Ugalde MT, Robles-Vidal C, Bargallo-Rocha E, Mohar-Betancourt A, Dueñas-González A.

Eur J Gynaecol Oncol. 2009;30(5):527-30.

PMID:
19899408
3.

BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation.

Vaidyanathan K, Lakhotia S, Ravishankar HM, Tabassum U, Mukherjee G, Somasundaram K.

J Biosci. 2009 Sep;34(3):415-22.

4.

A family history of breast cancer will not predict female early onset breast cancer in a population-based setting.

de Bock GH, Jacobi CE, Seynaeve C, Krol-Warmerdam EM, Blom J, van Asperen CJ, Cornelisse CJ, Klijn JG, Devilee P, Tollenaar RA, Brekelmans CT, van Houwelingen JC.

BMC Cancer. 2008 Jul 23;8:203. doi: 10.1186/1471-2407-8-203.

5.

[BRCA1/2 gene mutation in Chinese familial breast cancer patients: a multi-center report of 115 cases].

Hu Z, Li WF, Liu XY, Zhang B, Cao MZ, Wang YS, Zhao L, Song CG, Lu JS, Wu J, DI GH, Shen KW, Han QX, Shen ZZ, Huang W, Shao ZM.

Zhonghua Yi Xue Za Zhi. 2008 Sep 9;88(34):2383-6. Chinese.

PMID:
19087709
6.

Age-dependent penetrance of different germline mutations in the BRCA1 gene.

Al-Mulla F, Bland JM, Serratt D, Miller J, Chu C, Taylor GT.

J Clin Pathol. 2009 Apr;62(4):350-6. doi: 10.1136/jcp.2008.062646.

7.

Clinical and pathologic differences between BRCA1-, BRCA2-, and non-BRCA-associated breast cancers in a multiracial developing country.

Yip CH, Taib NA, Choo WY, Rampal S, Thong MK, Teo SH.

World J Surg. 2009 Oct;33(10):2077-81. doi: 10.1007/s00268-009-0146-8.

PMID:
19649760
8.

Mammary tumor development in dogs is associated with BRCA1 and BRCA2.

Rivera P, Melin M, Biagi T, Fall T, Häggström J, Lindblad-Toh K, von Euler H.

Cancer Res. 2009 Nov 15;69(22):8770-4. doi: 10.1158/0008-5472.CAN-09-1725. Epub 2009 Nov 3.

9.

Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation.

Seong MW, Cho S, Noh DY, Han W, Kim SW, Park CM, Park HW, Kim SY, Kim JY, Park SS.

Clin Genet. 2009 Aug;76(2):152-60. doi: 10.1111/j.1399-0004.2009.01202.x. Epub 2009 Jul 28.

PMID:
19656164
10.

Breast cancer prevention in BRCA1/2 mutation carriers: a qualitative review.

Fuller S, Liebens F, Carly B, Pastijn A, Rozenberg S.

Breast J. 2008 Nov-Dec;14(6):603-4. doi: 10.1111/j.1524-4741.2008.00661.x. Review. No abstract available.

PMID:
19054005
11.

BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.

Lim MC, Kang S, Seo SS, Kong SY, Lee BY, Lee SK, Park SY.

J Cancer Res Clin Oncol. 2009 Nov;135(11):1593-9. doi: 10.1007/s00432-009-0607-3. Epub 2009 Jun 5.

PMID:
19499246
12.

A principle-based approach to ethical issues in predictive genetic testing for breast cancer.

Quillin JM, Lyckholm LJ.

Breast Dis. 2006-2007;27:137-48. Review.

PMID:
17917145
13.

A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example.

Mohammadi L, Vreeswijk MP, Oldenburg R, van den Ouweland A, Oosterwijk JC, van der Hout AH, Hoogerbrugge N, Ligtenberg M, Ausems MG, van der Luijt RB, Dommering CJ, Gille JJ, Verhoef S, Hogervorst FB, van Os TA, Gómez García E, Blok MJ, Wijnen JT, Helmer Q, Devilee P, van Asperen CJ, van Houwelingen HC.

BMC Cancer. 2009 Jun 29;9:211. doi: 10.1186/1471-2407-9-211.

14.

Experiences of genetic counseling for BRCA1/2 among recently diagnosed breast cancer patients: a qualitative inquiry.

Vadaparampil ST, Quinn GP, Brzosowicz J, Miree CA.

J Psychosoc Oncol. 2008;26(4):33-52.

PMID:
19042271
15.

[Relationship between mutation of BRCA1 and susceptibility to early onset of breast cancer].

Meng J, Shi YR, Niu RF, Fu L.

Zhonghua Yi Xue Za Zhi. 2009 Jan 13;89(2):79-82. Chinese.

PMID:
19489266
16.

Update on genetic predisposition to breast cancer.

Ahmed M, Lalloo F, Evans DG.

Expert Rev Anticancer Ther. 2009 Aug;9(8):1103-13. doi: 10.1586/era.09.38. Review.

PMID:
19671030
17.

BRCA1/2 genetic testing found cost-effective in current era.

Goodman A.

Am J Manag Care. 2012 May;18(3 Spec No.):SP133. No abstract available.

18.

The contribution of BRCA1 and BRCA2 to ovarian cancer.

Ramus SJ, Gayther SA.

Mol Oncol. 2009 Apr;3(2):138-50. doi: 10.1016/j.molonc.2009.02.001. Epub 2009 Feb 10. Review.

19.

A decade of discovery of BRCA1 and BRCA2: are we turning the tide against hereditary breast cancers?

Sarin R.

J Cancer Res Ther. 2006 Oct-Dec;2(4):157-8. Review. No abstract available.

20.

Re: Pregnancies, breastfeeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).

Huiart L, Sylvestre MP.

J Natl Cancer Inst. 2007 Jul 18;99(14):1130-1; author reply 1131. Epub 2007 Jul 10. No abstract available.

PMID:
17623800

Supplemental Content

Support Center